NanoVibronix (NAOV) stock underwent a massive rally on Monday after the medical device company was granted a patent by the U.S. Patent and Trademark Office. The patent, titled “Insertion Device Positioning Guidance System and Method”, was granted to NanoVibronix subsidiary ENvue Medical Holdings. It covers the “proprietary systems and methods for guiding the insertion of medical devices such as feeding tubes using electromagnetic positioning technology.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NanoVibronix CEO Doron Besser highlighted the importance of this patent. He said that it “underscores our commitment to advancing solutions that improve patient outcomes while enhancing procedural efficiency.” The company CEO also pointed out that this is a move forward with its plan to build an IP portfolio that protects NanoVibronix’s proprietary technology.
NanoVibronix noted that the latest patent strengthens its portfolio, and that the company is dedicated to protecting its competitive advantage. All of this is designed to help the company grow in its field.
NanoVibronix Stock Movement Today
NanoVibronix stock was up 58.86% in pre-market trading on Monday, following a 3.84% rally on Friday. However, the shares have fallen 90% year-to-date and 91.69% over the past 12 months. Today’s news came with heavy trading, as some 11 million shares changed hands, compared to a three-month daily average of about 98,000 units.
Source link
